Live feed
·
INSIDERFilingvia Quantisnow
Bolt Biotherapeutics Inc. logo

President, CEO and CFO Quinn William P. bought $686 worth of shares (125 units at $5.49) and was granted 40,000 shares, increasing direct ownership by 1,945% to 42,188 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BOLT· Bolt Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BOLT (Bolt Biotherapeutics Inc.) and more on Quantisnow.